Caplight Directory>Companies>Enedra Therapeutics-preview>Enedratx


Enedra Therapeutics

Enedra Therapeutics

Private
LondonHealthcare & Life Scienceshttps://enedratx.com/

Last Round

VC Round

May 6, 2025

Company Overview

Enedra Therapeutics is a biotechnology company developing next-generation precision therapies for advanced, genetically heterogeneous cancers. The company leverages its proprietary AI-driven CASPAROV platform to discover novel drug targets and patient-specific biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

AI drug discoverydrug target discoveryprecision oncologytechbioAI biotechdrug discovery platformcomputational biologybioinformaticsin silico drug discoverygenomics platformtumor heterogeneitytherapeutic resistancepreclinical biotechfirst-in-class drugsbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enedra Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Enedra Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 6, 2025
View all Funding Rounds

Enedra Therapeutics Investors

Notable investors and investment history

InvestorRounds
Deep Science VenturesSeed, VC Round
o2h venturesVC Round
Centre for Drug Design and DiscoveryVC Round
Cancer Research HorizonsSeed, VC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 6, 2025

    Raised VC Round led by o2h ventures and Centre for Drug Design and Discovery.

View all signals

Enedra Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enedra Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enedra Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Year Founded2021
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.